Description

Bacille Calmette-Guerin (BCG) may be instilled into the bladder of a patient with a bladder cancer to induce a host immunologic response that can aid in tumor control. The instilled organisms usually cause a chronic cystitis limited to the bladder wall. Rarely the organism can spread beyond the bladder to cause a localized or disseminated infection.


 

Risk factors for infection beyond the bladder:

(1) patient immunocompromised, especially with defective cellular immunity

(2) improper administration (inexperienced, difficulty performing, other)

(3) BCG administration shortly after extensive tumor resection

(4) traumatic catheterization or urethral trauma

(5) high voiding pressure

 

Infections that have been reported:

(1) localized abscess (psoas muscle, other)

(2) disseminated disease with miliary spread

(3) pneumonitis

(4) granulomatous hepatitis

(5) pancytopenia (due to involvement of the bone marrow)

 

Clinical findings:

(1) fever

(2) malaise

(3) symptoms based on extent of the infection

(4) positive culture for Mycobacterium bovis identical to the strain of BCG administered

 

Most patients respond to a short course of isoniazid therapy.

 

Differential diagnosis:

(1) anaphylaxis

(2) urosepsis

 


To read more or access our algorithms and calculators, please log in or register.